Dec. 13, 2022

Formlabs 3D Printers Receive Innovative Technology Designation from Vizient

Designation recognizes Vizient-contracted products that bring improvements to the healthcare industry.

Somerville, MA, Dec. 13, 2022Formlabs, the leading 3D printing company, today announced its 3D printers have received an Innovative Technology designation from Vizient, Inc., the largest healthcare performance improvement company in the country. Formlabs exhibited its 3D printers at the Vizient Innovative Technology Exchange Oct. 17 in Dallas.

Each year, healthcare experts serving on Vizient member-led councils review select products and technologies for their potential to enhance clinical care, patient safety, healthcare worker safety or to improve business operations of healthcare organizations. Innovative Technology designations are awarded to highlight previously contracted products for their potential impact on patient care or business models of healthcare organizations.

Formlabs democratized access to 3D printing with its affordable, professional-grade technology that is validated in multiple FDA 510(k) cleared processes for manufacturing of surgical tools either within the hospital or by third-party vendors. Traditionally, 3D printing technology was prohibitively expensive for a majority of hospitals and only available to the largest, most well-resourced medical centers. Formlabs technology is utilized in hundreds of facilities ranging from world-renowned institutions, to less-resourced, safety-net hospitals in the U.S. and abroad, demonstrating the performance, acceptance, and accessibility of Formlabs medical materials, printers, and FDA-cleared processes. The company's printers and medical device materials have been highlighted in over 1,500 publications in the field of medicine.

“We are honored to receive this recognition from Vizient,” said Guillaume Bailliard, Formlabs President of Healthcare. “This award further underscores the importance of 3D printing in the medical community, and we are committed to continuing to make our products more accessible to medical professionals around the world.”

“Congratulations to Formlabs for achieving this peer-designated status,” said Kelly Flaharty, Vizient senior director of contract services. “Our member council deemed Formlabs’s 3D printers worthy of this designation for its potential to make an incremental difference in health care.”

A wealth of clinical literature demonstrates that Formlabs’ 3D printed anatomical models and surgical guides reduce the time spent preparing for surgery and in the operating room, lower infection rates and perioperative blood loss, and improve surgeon confidence, patient consent, and clinical outcomes. Surgical tools printed with Formlabs’ low-cost technology are validated for diagnostic use in several FDA-cleared workflows and trusted by hundreds of hospitals, surgical centers, imaging centers, and medical schools globally, as well as thousands of medical device firms. For more information on Formlabs’ hospital-specific applications click here. For media assets click here.

Vizient represents a diverse membership that includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute healthcare providers and represents approximately $130 billion in annual purchasing volume. Through its Innovative Technology Program, Vizient works with member-led councils and task forces to evaluate products for their potential to bring real innovation to healthcare. Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

About Formlabs Healthcare
Formlabs is expanding access to digital fabrication, so anyone can make anything. By combining clinically-validated 3D printing technology, in-house QA/RA expertise, accessible pricing, and a wide range of materials, the company enables healthcare professionals and medical device engineers to enhance surgery, radiology, orthotics and prosthetics, and device development. Formlabs has FDA-registered, ISO 13485 certified manufacturing facilities and a wide range of biocompatible, sterilizable materials made for both SLA and SLS print engines. Its solutions have been used in thousands of publications and are trusted by the world’s leading health systems and medical device manufacturers.

Formlabs Media Contact
Laura Shubel
BIGfish Communications for Formlabs
[email protected]